{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:46:46Z","timestamp":1773748006100,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The relationship between proteinuria and thyroid function remains controversial in patients with chronic kidney disease (CKD). We prospectively investigated the association between kidney and thyroid function in thyroid antibody-negative patients through all CKD stages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled 184 nondialysis patients (mean age: 63.1\u2009\u00b1\u200916.9 years) without previous thyroid disease or thyroid-specific antibodies. Kidney function was assessed by estimating the glomerular filtration rate (eGFR) classified according KDIGO (CKD G1\u20135). Kidney damage was assessed by albuminuria (albumin-to-creatinine ratio, ACR) and classified as mild, moderate, or severe (ACR1: &lt;300, ACR2: 300\u20133000, and ACR3: 3000\u2009mg\/g). To evaluate thyroid function, TSH, T4, fT4, T3, fT3, reverse T3 (rT3), and thyroxine-binding globulin (TBG) were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>rT3 concentrations correlated negatively with albuminuria (<jats:italic>r<\/jats:italic>\u2009=\u2009\u22120.286, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and were significantly lower in patients with severe albuminuria than in those with mild or moderate albuminuria (ACR3: 0.28 vs. ACR2: 0.32 vs. ACR1: 0.36\u2009nmol\/l, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The severity of albuminuria revealed no impact on TSH, fT4, T3, fT3, and TBG. EGFR correlated with increasing T4, fT4, T3, fT3, and TBG (T4: <jats:italic>r<\/jats:italic>\u2009=\u20090.289, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; fT4: <jats:italic>r<\/jats:italic>\u2009=\u20090.196, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; T3: <jats:italic>r<\/jats:italic>\u2009=\u20090.408, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; fT3: <jats:italic>r<\/jats:italic>\u2009=\u20090.390, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) but not with rT3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In thyroid antibody-negative patients presenting advanced CKD (stages 4 and 5), even severe kidney protein loss failed to influence thyroid hormone status. However, albuminuria severity correlated negatively with rT3, which was significantly lower in patients with albuminuria in the nephrotic range.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-021-02640-1","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T18:10:57Z","timestamp":1613067057000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between albuminuria and thyroid function in patients with chronic kidney disease"],"prefix":"10.1007","volume":"73","author":[{"given":"Walter","family":"Reinhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3534-233X","authenticated-orcid":false,"given":"Nils","family":"M\u00fclling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Dolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"F\u00fchrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"2640_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","volume":"341","author":"E Ritz","year":"1999","unstructured":"E. Ritz, S.R. Orth, Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 341, 1127\u20131133 (1999)","journal-title":"N. Engl. J. Med."},{"key":"2640_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"A.S. Levey, P.E. de Jong, J. Coresh et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 80, 17\u201328 (2011)","journal-title":"Kidney Int."},{"key":"2640_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/jcem-42-3-504","volume":"42","author":"CW Burke","year":"1976","unstructured":"C.W. Burke, R.A. Shakespear, Triiodothyronine and thyroxine in urine. II. Renal handling, and effect of urinary protein. J. Clin. Endocrinol. Metab. 42, 504\u2013513 (1976)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2640_CR4","first-page":"257","volume":"37","author":"N Etling","year":"1982","unstructured":"N. Etling, F. Fouque, Effect of prednisone on serum and urinary thyroid hormone levels in children during the nephrotic syndrome. Helv. Paediatr. Acta 37, 257\u2013265 (1982)","journal-title":"Helv. Paediatr. Acta"},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00856516","volume":"8","author":"S Ito","year":"1994","unstructured":"S. Ito, K. Kano, T. Ando et al. Thyroid function in children with nephrotic syndrome. Pediatr. Nephrol. 8, 412\u2013415 (1994)","journal-title":"Pediatr. Nephrol."},{"key":"2640_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0140-6736(91)90546-2","volume":"338","author":"V Fonseca","year":"1991","unstructured":"V. Fonseca, M. Thomas, A. Katrak et al. Can urinary thyroid hormone loss cause hypothyroidism? Lancet 338, 475\u2013476 (1991)","journal-title":"Lancet"},{"key":"2640_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4158\/EP.14.1.97","volume":"14","author":"V Chandurkar","year":"2008","unstructured":"V. Chandurkar, J. Shik, E. Randell, Exacerbation of underlying hypothyroidism caused by proteinuria and induction of urinary thyroxine loss: case report and subsequent investigation. Endocr. Pract. 14, 97\u2013103 (2008)","journal-title":"Endocr. Pract."},{"key":"2640_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/0003-4819-90-3-335","volume":"90","author":"MA Afrasiabi","year":"1979","unstructured":"M.A. Afrasiabi, N.D. Vaziri, G. Gwinup et al. Thyroid function studies in the nephrotic syndrome. Ann. Intern. Med. 90, 335\u2013338 (1979)","journal-title":"Ann. Intern. Med."},{"key":"2640_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/acta.0.1020367","volume":"102","author":"F Adlkofer","year":"1983","unstructured":"F. Adlkofer, H. Hain, H. Meinhold et al. Thyroid function in patients with proteinuria and normal or increased serum creatinine concentration. Acta Endocrinol. 102, 367\u2013376 (1983)","journal-title":"Acta Endocrinol."},{"key":"2640_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1210\/jcem-46-1-125","volume":"46","author":"LA Gavin","year":"1978","unstructured":"L.A. Gavin, F.A. McMahon, J.N. Castle et al. Alterations in serum thyroid hormones and thyroxine-binding globulin in patients with nephrosis. J. Clin. Endocrinol. Metab. 46, 125\u2013130 (1978)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2640_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000381310","volume":"4","author":"S Benvenga","year":"2015","unstructured":"S. Benvenga, R. Vita, F. Di Bari et al. Do not forget nephrotic syndrome as a cause of increased requirement of levothyroxine replacement therapy. Eur. Thyroid J. 4(2), 138\u2013142 (2015)","journal-title":"Eur. Thyroid J."},{"key":"2640_CR12","first-page":"201","volume":"52","author":"NA Junglee","year":"2006","unstructured":"N.A. Junglee, M.F. Scanlon, D.A. Rees, Increasing thyroxine requirements in primary hypothyroidism: don\u2019t forget the urinalysis! J. Postgrad. Med. 52, 201\u2013203 (2006)","journal-title":"J. Postgrad. Med."},{"key":"2640_CR13","first-page":"153","volume":"67","author":"C Halma","year":"2009","unstructured":"C. Halma, Thyroid function in patients with proteinuria. Neth. J. Med. 67, 153 (2009)","journal-title":"Neth. J. Med."},{"key":"2640_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/01.med.0000433069.09294.e8","volume":"20","author":"AP Farwell","year":"2013","unstructured":"A.P. Farwell, Nonthyroidal illness syndrome. Curr. Opin. Endocrinol. Diabetes Obes. 20, 478\u2013484 (2013)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2640_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1210\/jcem-57-1-181","volume":"57","author":"EM Kaptein","year":"1983","unstructured":"E.M. Kaptein, E.I. Feinstein, J.T. Nicoloff et al. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. J. Clin. Endocrinol. Metab. 57, 181\u2013189 (1983)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2640_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1055\/s-2007-976536","volume":"39","author":"O Witzke","year":"2007","unstructured":"O. Witzke, J. Wiemann, D. Patschan et al. Differential T4 degradation pathways in young patients with preterminal and terminal renal failure. Horm. Metab. Res. 39, 355\u2013358 (2007)","journal-title":"Horm. Metab. Res."},{"key":"2640_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000181957","volume":"26","author":"J Kosowicz","year":"1980","unstructured":"J. Kosowicz, B. Malczewska, S. Czekalski, Serum reverse triiodothyronine (3,3\u2019,5\u2019-L-triiodothyronine) in chronic renal failure. Nephron 26, 85\u201389 (1980)","journal-title":"Nephron"},{"key":"2640_CR18","first-page":"189","volume":"27","author":"S De Marchi","year":"1987","unstructured":"S. De Marchi, E. Cecchin, D. Villalta et al. Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy. Clin. Nephrol. 27, 189\u2013198 (1987)","journal-title":"Clin. Nephrol."},{"key":"2640_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000166587","volume":"2","author":"EI Feinstein","year":"1982","unstructured":"E.I. Feinstein, E.M. Kaptein, J.T. Nicoloff et al. Thyroid function in patients with nephrotic syndrome and normal renal function. Am. J. Nephrol. 2, 70\u201376 (1982)","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"2640_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2215\/CJN.05250511","volume":"7","author":"CL Meuwese","year":"2012","unstructured":"C.L. Meuwese, F.W. Dekker, B. Lindholm et al. Baseline levels and trimestral variation of triiodthyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin. J. Am. Soc. Nephrol. 7(1), 131\u2013138 (2012)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2640_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ndt\/gfu303","volume":"30","author":"CM Rhee","year":"2015","unstructured":"C.M. Rhee, K. Kalantar-Zadeh, E. Streja et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol. Dial. Transplant. 30, 282\u2013287 (2015)","journal-title":"Nephrol. Dial. Transplant."},{"key":"2640_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1365-2265.1997.1770988.x","volume":"46","author":"W Reinhardt","year":"1997","unstructured":"W. Reinhardt, C. Misch, F. Jockenhovel et al. Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin. Endocrinol. 46, 563\u2013569 (1997)","journal-title":"Clin. Endocrinol."},{"key":"2640_CR23","first-page":"483","volume":"66","author":"R Gilles","year":"2008","unstructured":"R. Gilles, M. den Heijer, A.H. Ross et al. Thyroid function in patients with proteinuria. Neth. J. Med. 66, 483\u2013485 (2008)","journal-title":"Neth. J. Med."},{"key":"2640_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep41302","volume":"7","author":"X Du","year":"2017","unstructured":"X. Du, B. Pan, W. Li et al. Albuminuria is an independent risk factor of T4 elevation in chronic kidney disease. Sci. Rep. 7, 41302 (2017)","journal-title":"Sci. Rep."},{"issue":"2","key":"2640_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.15386\/mpr-1091","volume":"92","author":"D Jain","year":"2019","unstructured":"D. Jain, H.K. Aggarwal, Y.M. Pavan Kumar et al. Evaluation of thyroid dysfunction in patients with nephrotic syndrome. Med. Pharm. Rep. 92(2), 139\u2013144 (2019). https:\/\/doi.org\/10.15386\/mpr-1091. Epub 25 Apr 2019","journal-title":"Med. Pharm. Rep."},{"key":"2640_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42905-4","volume":"9","author":"L-Z Li","year":"2019","unstructured":"L.-Z. Li, Y. Hu, S.-L. Ai et al. The relationship between thyroid dysfunction and nephrotic syndrome: a clinicopathological stduy. Sci. Rep. 9, 6421 (2019)","journal-title":"Sci. Rep."},{"key":"2640_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/0886022X.2011.647342","volume":"34","author":"JW Yang","year":"2012","unstructured":"J.W. Yang, S.T. Han, S.H. Song et al. Serum T3 level can predict cardiovascular events and all-cause mortality rates in CKD patients with proteinuria. Ren. Fail. 34, 364\u2013372 (2012)","journal-title":"Ren. Fail."},{"issue":"10","key":"2640_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1089\/thy.2015.0097","volume":"25","author":"W Reinhardt","year":"2015","unstructured":"W. Reinhardt, S. Dolff, S. Benson, M. Broecker-Preu\u00df, S. Behrendt, A. H\u00f6g, D. F\u00fchrer, L. Schomburg, J. K\u00f6hrle. Chronic Kidney disease distinctly affects relationship between selenoprotein P status and serum thyroid hormone parameters. Thyroid 25(10), 1091\u20131096 (2015). Epub 8 Sep 2015 https:\/\/doi.org\/10.1089\/thy.2015.0097","journal-title":"Thyroid"},{"key":"2640_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","volume":"63","author":"AS Levey","year":"2014","unstructured":"A.S. Levey, L.A. Inker, J. Coresh, GFR estimation: from physiology to public health. Am. J. Kidney Dis. 63, 820\u2013834 (2014)","journal-title":"Am. J. Kidney Dis."},{"key":"2640_CR30","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/ndt\/gfr665","volume":"27","author":"A Dagan","year":"2012","unstructured":"A. Dagan, R. Cleper, I. Krause et al. Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrol. Dial. Transplant. 27, 2171\u20132175 (2012)","journal-title":"Nephrol. Dial. Transplant."},{"key":"2640_CR31","doi-asserted-by":"publisher","first-page":"256420","DOI":"10.4061\/2011\/256420","volume":"2011","author":"SU Sawant","year":"2011","unstructured":"S.U. Sawant, S. Chandran, A.F. Almeida et al. Correlation between oxidative stress and thyroid function in patients with nephrotic syndrome. Int. J. Nephrol. 2011, 256420 (2011)","journal-title":"Int. J. Nephrol."},{"issue":"4 Pt 1","key":"2640_CR32","doi-asserted-by":"publisher","first-page":"E641","DOI":"10.1152\/ajpendo.1991.260.4.E641","volume":"260","author":"EM Kaptein","year":"1991","unstructured":"E.M. Kaptein, M.T. Hoopes, M. Parise et al. rT3 metabolism in patients with nephrotic syndrome and normal GFR compared with normal subjects. Am. J. Physiol. 260(4 Pt 1), E641\u2013E650 (1991). https:\/\/doi.org\/10.1152\/ajpendo.1991.260.4.E641","journal-title":"Am. J. Physiol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02640-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T18:40:10Z","timestamp":1625683210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02640-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02640-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"28 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The participants have consented to the submission of the manuscript to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Authors\u2019 local ethics committee approved the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study to undergo testing and to be included in this pseudonymized analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}